“Protective effects of paeonol on cardiovascular complications in diabetes mellitus involves modulation of PI3K /Akt-GSK-3β signalling, regulation of protease-activated receptor-1 expressions and down-regulation of inflammatory mediators” (2015) Bangladesh Journal of Pharmacology, 10(4), pp. 903–916. doi:10.3329/bjp.v10i4.24334.